Intra-nasal infection of macaques with Yellow Fever (YF) vaccine strain 17D: a novel and economical approach for YF vaccination in man

By Niedrig M.   Stolte N.   Fuchs D.   Hunsmann G.   Stahl-Hennig C.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1206-1210

Elsevier

Access to resources Recommend Favorite

Genetic variability among yellow fever virus 17D substrains

By Galler R.   Post P.R.   Santos C.N.D.   Ferreira I.I.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 1024-1028

Elsevier

Access to resources Recommend Favorite

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax&unknown;) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective i

By Monath T.P.   Soike K.   Levenbook I.   Zhang Z.-X.   Arroyo J.   Delagrave S.   Myers G.   Barrett A.D.T.   Shope R.E.   Ratterree M.   Chambers T.J.   Guirakhoo F.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1869-1882

Elsevier

Access to resources Recommend Favorite

A rapid test for measuring the infectivity of Yellow Fever vaccine

By Sood D.K.   Aggarwal R.K.   Kumar S.   Sokhey J.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 427-428

Elsevier

Access to resources Recommend Favorite

Yellow fever vaccine safety: a reality or a myth?

By Arya S.C.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3627-3628

Elsevier

Access to resources Recommend Favorite